Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
bevacizumab complement c1q subcomponent subunit a biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab complement c1q subcomponent subunit a biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab complement c1q subcomponent subunit b biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab complement c1q subcomponent subunit b biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab complement c1q subcomponent subunit c biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab complement c1q subcomponent subunit c biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab high affinity immunoglobulin gamma fc receptor i biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab high affinity immunoglobulin gamma fc receptor i biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor ii-a biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor ii-a biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor ii-b biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor ii-b biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor ii-c biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor ii-c biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor iii-a biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 NA approved,investigational unknown
bevacizumab low affinity immunoglobulin gamma fc region receptor iii-a biotech NA drugbank Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 NA approved,investigational unknown
bevacizumab vascular endothelial growth factor a biotech Successful target TTD , drugbank , DGIDB Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 1.08 approved,investigational unknown
bevacizumab vascular endothelial growth factor a biotech Successful target TTD , drugbank , DGIDB Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 1.08 approved,investigational antibody
bevacizumab vascular endothelial growth factor a biotech Successful target TTD , drugbank , DGIDB Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 1.08 approved,investigational inhibitor
bevacizumab vascular endothelial growth factor a biotech Successful target TTD , drugbank , DGIDB Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 1.08 approved,investigational inhibitor
bevacizumab vascular endothelial growth factor a biotech Successful target TTD , drugbank , DGIDB Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Colorectal Cancer[MeSHID:D015179]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 1.08 approved,investigational antibody
bevacizumab vascular endothelial growth factor a biotech Successful target TTD , drugbank , DGIDB Epithelial ovarian cancer[MeSHID:C538090]
Malignant Neoplasms[MeSHID:D009369]
Respiratory Distress Syndrome
Adult[MeSHID:D012128]
Renal Cell Carcinoma[MeSHID:D002292]
Acute Lung Injury[MeSHID:D055371]
Neoplasm Metastasis[MeSHID:D009362]
Fallopian Tube Carcinoma[MeSHID:D005185]
Peritoneum[MeSHID:D010537]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Glioblastoma[MeSHID:D005909]
Recurrence (disease attribute)[MeSHID:D012008]
cervical cancer[MeSHID:D002583]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Brain[MeSHID:D001921]
Malignant neoplasm of lung[MeSHID:D008175]
Colorectal Cancer[MeSHID:D015179]
Malignant neoplasm of ovary[MeSHID:D010051]		 1.08 approved,investigational unknown
click here to return to the previous page